[1] |
HELMAN A, MELTON DA. A stem cell approach to cure type 1 diabetes[J]. Cold Spring Harb Perspect Biol, 2021, 13(1): a035741. DOI: 10.1101/cshperspect.a035741.
|
[2] |
NAQVI RA, NAQVI AR, SINGH A, et al. The future treatment for type 1 diabetes: pig islet- or stem cell-derived β cells?[J]. Front Endocrinol (Lausanne), 2023, 13: 1001041. DOI: 10.3389/fendo.2022.1001041.
|
[3] |
罗说明, 周智广. 1型糖尿病治疗新技术的现状与未来[J]. 中国医师杂志, 2023, 25(3): 321-324. DOI: 10.3760/cma.j.cn431274-20230215-00159.LUO SM, ZHOU ZG. Current status and future of new technologies in the treatment of type 1 diabetes[J]. J Chin Physician, 2023, 25(3): 321-324. DOI: 10.3760/cma.j.cn431274-20230215-00159.
|
[4] |
杨玉伟, 张婷, 李万里, 等. 胰岛移植即刻经血液介导的炎症反应应对策略[J]. 器官移植, 2023, 14(3): 352-357. DOI: 10.3969/j.issn.1674-7445.2023.03.005.YANG YW, ZHANG T, LI WL, et al. Therapeutic strategy for instant blood-mediated inflammatory reaction after islet transplantation[J]. Organ Transplant, 2023, 14(3): 352-357. DOI: 10.3969/j.issn.1674-7445.2023.03.005.
|
[5] |
MARFIL-GARZA BA, IMES S, VERHOEFF K, et al. Pancreatic islet transplantation in type 1 diabetes: 20-year experience from a single-centre cohort in Canada[J]. Lancet Diabetes Endocrinol, 2022, 10(7): 519-532. DOI: 10.1016/S2213-8587(22)00114-0.
|
[6] |
WALKER S, APPARI M, FORBES S. Considerations and challenges of islet transplantation and future therapies on the horizon[J]. Am J Physiol Endocrinol Metab, 2022, 322(2): E109-E117. DOI: 10.1152/ajpendo.00310.2021.
|
[7] |
MARFIL-GARZA BA, SHAPIRO AMJ, KIN T. Clinical islet transplantation: current progress and new frontiers[J]. J Hepatobiliary Pancreat Sci, 2021, 28(3): 243-254. DOI: 10.1002/jhbp.891.
|
[8] |
QU Z, LOU Q, COOPER DKC, et al. Potential roles of mesenchymal stromal cells in islet allo- and xenotransplantation for type 1 diabetes mellitus[J]. Xenotransplantation, 2021, 28(3): e12678. DOI: 10.1111/xen.12678.
|
[9] |
NGUYEN TT, PHAM DV, PARK J, et al. Engineering of hybrid spheroids of mesenchymal stem cells and drug depots for immunomodulating effect in islet xenotransplantation[J]. Sci Adv, 2022, 8(34): eabn8614. DOI: 10.1126/sciadv.abn8614.
|
[10] |
KIKUCHI T, NISHIMURA M, KOMORI N, et al. Development and characterization of islet-derived mesenchymal stem cells from clinical grade neonatal porcine cryopreserved islets[J]. Xenotransplantation, 2023,DOI: 10.1111/xen.12831[Epub ahead of print
|
[11] |
师越, 李燕, 金慧方, 等. 人间充质干细胞质量研究及评价进展[J]. 国际生物医学工程杂志, 2023, 46(3): 275-280. DOI: 10.3760/cma.j.cn121382-20230411-00315.SHI Y, LI Y, JIN HF, et al. Research progress in quality research and evaluation of human mesenchymal stem cells[J]. Int J Biomed Eng, 2023, 46(3): 275-280. DOI: 10.3760/cma.j.cn121382-20230411-00315.
|
[12] |
WANG Y, FANG J, LIU B, et al. Reciprocal regulation of mesenchymal stem cells and immune responses[J]. Cell Stem Cell, 2022, 29(11): 1515-1530. DOI: 10.1016/j.stem.2022.10.001.
|
[13] |
WANG LT, LIU KJ, SYTWU HK, et al. Advances in mesenchymal stem cell therapy for immune and inflammatory diseases: use of cell-free products and human pluripotent stem cell-derived mesenchymal stem cells[J]. Stem Cells Transl Med, 2021, 10(9): 1288-1303. DOI: 10.1002/sctm.21-0021.
|
[14] |
潘兴华, 王颖翠, 张梦园, 等. 脐带间充质干细胞临床研究的伦理与安全问题[J]. 西南国防医药, 2018, 28(1): 4-6. DOI: 10.3969/j.issn.1004-0188.2018.01.002.PAN XH, WANG YC, ZHANG MY, et al. Ethical and safety issues in clinical research of umbilical cord mesenchymal stem cells[J]. Med J Natl Defend Forces Southwest China, 2018, 28(1): 4-6. DOI: 10.3969/j.issn.1004-0188.2018.01.002.
|
[15] |
NISHIMURA M, NGUYEN L, WATANABE N, et al. Development and characterization of novel clinical grade neonatal porcine bone marrow-derived mesenchymal stem cells[J]. Xenotransplantation, 2019, 26(3): e12501. DOI: 10.1111/xen.12501.
|
[16] |
GARCIA GA, OLIVEIRA RG, DARIOLLI R, et al. Isolation and characterization of farm pig adipose tissue-derived mesenchymal stromal/stem cells[J]. Braz J Med Biol Res, 2022, 55: e12343. DOI: 10.1590/1414-431X2022e12343.
|
[17] |
TERATANI T, KASAHARA N, FUJIMOTO Y, et al. Mesenchymal stem cells secretions enhanced ATP generation on isolated islets during transplantation[J]. Islets, 2022, 14(1): 69-81. DOI: 10.1080/19382014.2021.2022423.
|
[18] |
淮国丽, 杜嘉祥, 潘登科. 基因编辑猪用于急性肝衰竭治疗的路径探讨[J]. 临床肝胆病杂志, 2022, 38(10): 2214-2218. DOI: 10.3969/j.issn.1001-5256.2022.10.004.HUAI GL, DU JX, PAN DK. The discussion on the genetically modified pigs for the treatment of acute liver failure[J]. J Clin Hepatol, 2022, 38(10): 2214-2218. DOI: 10.3969/j.issn.1001-5256.2022.10.004.
|
[19] |
SYKES M, SACHS DH. Progress in xenotransplantation: overcoming immune barriers[J]. Nat Rev Nephrol, 2022, 18(12): 745-761. DOI: 10.1038/s41581-022-00624-6.
|
[20] |
QI C, PANG D, YANG K, et al. Generation of PCBP1-deficient pigs using CRISPR/Cas9-mediated gene editing[J]. iScience, 2022, 25(10): 105268. DOI: 10.1016/j.isci.2022.105268.
|
[21] |
PIERSON RN 3RD. Progress toward pig-to-human xenotransplantation[J]. N Engl J Med, 2022, 386(20): 1871-1873. DOI: 10.1056/NEJMp2118019.
|
[22] |
DOS SANTOS RMN. Kidney xenotransplantation: are we ready for prime time?[J]. Curr Urol Rep, 2023, 24(6): 287-297. DOI: 10.1007/s11934-023-01156-7.
|
[23] |
BURLAK C, TAYLOR RT, WANG ZY, et al. Human anti-α-fucose antibodies are xenoreactive toward GGTA1/CMAH knockout pigs[J]. Xenotransplantation, 2020, 27(6): e12629. DOI: 10.1111/xen.12629.
|
[24] |
DING F, LIN Y, LIU G, et al. Immune disguise: the mechanisms of Neu5Gc inducing autoimmune and transplant rejection[J]. Genes Immun, 2022, 23(6): 175-182. DOI: 10.1038/s41435-022-00182-8.
|
[25] |
YOON S, LEE S, PARK C, et al. An efficacious transgenic strategy for triple knockout of xeno-reactive antigen genes GGTA1, CMAH, and B4GALNT2 from Jeju native pigs[J]. Vaccines (Basel), 2022, 10(9): 1503. DOI: 10.3390/vaccines10091503.
|
[26] |
JAGDALE A, NGUYEN H, LI J, et al. Does expression of a human complement-regulatory protein on xenograft cells protect them from systemic complement activation?[J]. Int J Surg, 2020, 83: 184-188. DOI: 10.1016/j.ijsu.2020.09.034.
|
[27] |
CHABAN R, MCGRATH G, HABIBABADY Z, et al. Increased human complement pathway regulatory protein gene dose is associated with increased endothelial expression and prolonged survival during ex-vivo perfusion of GTKO pig lungs with human blood[J]. Xenotransplantation, 2023, 30(4): e12812. DOI: 10.1111/xen.12812.
|
[28] |
BURDORF L, LAIRD CT, HARRIS DG, et al. Pig-to-baboon lung xenotransplantation: extended survival with targeted genetic modifications and pharmacologic treatments[J]. Am J Transplant, 2022, 22(1): 28-45. DOI: 10.1111/ajt.16809.
|
[29] |
KIKUCHI T, NISHIMURA M, HIRATA M, et al. Development and characterization of Gal KO porcine bone marrow-derived mesenchymal stem cells[J]. Xenotransplantation, 2021, 28(6): e12717. DOI: 10.1111/xen.12717.
|
[30] |
TECTOR AJ, MOSSER M, TECTOR M, et al. The possible role of anti-Neu5Gc as an obstacle in xenotransplantation[J]. Front Immunol, 2020, 11: 622. DOI: 10.3389/fimmu.2020.00622.
|
[31] |
GALILI U. The alpha-gal epitope and the anti-Gal antibody in xenotransplantation and in cancer immunotherapy[J]. Immunol Cell Biol, 2005, 83(6): 674-686. DOI: 10.1111/j.1440-1711.2005.01366.x.
|
[32] |
RAO JS, HOSNY N, KUMBHA R, et al. HLA-G1+ expression in GGTA1KO pigs suppresses human and monkey anti-pig T, B and NK cell responses[J]. Front Immunol, 2021, 12: 730545. DOI: 10.3389/fimmu.2021.730545.
|
[33] |
CHABAN R, HABIBABADY Z, HASSANEIN W, et al. Knock-out of N-glycolylneuraminic acid attenuates antibody-mediated rejection in xenogenically perfused porcine lungs[J]. Xenotransplantation, 2022, 29(6): e12784. DOI: 10.1111/xen.12784.
|
[34] |
LANDSTRA CP, NIJHOFF MF, ROELEN DL, et al. Diagnosis and treatment of allograft rejection in islet transplantation[J]. Am J Transplant, 2023, 23(9): 1425-1433. DOI: 10.1016/j.ajt.2023.05.035.
|
[35] |
JEYAGARAN A, LU CE, ZBINDEN A, et al. Type 1 diabetes and engineering enhanced islet transplantation[J]. Adv Drug Deliv Rev, 2022, 189: 114481. DOI: 10.1016/j.addr.2022.114481.
|
[36] |
KABAKCHIEVA P, ASSYOV Y, GERASOUDIS S, et al. Islet transplantation-immunological challenges and current perspectives[J]. World J Transplant, 2023, 13(4): 107-121. DOI: 10.5500/wjt.v13.i4.107.
|
[37] |
SONG N, SCHOLTEMEIJER M, SHAH K. Mesenchymal stem cell immunomodulation: mechanisms and therapeutic potential[J]. Trends Pharmacol Sci, 2020, 41(9): 653-664. DOI: 10.1016/j.tips.2020.06.009.
|
[38] |
SHEN Z, HUANG W, LIU J, et al. Effects of mesenchymal stem cell-derived exosomes on autoimmune diseases[J]. Front Immunol, 2021, 12: 749192. DOI: 10.3389/fimmu.2021.749192.
|